Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodium ferulate is the sodium salt of ferulic acid, a phenolic compound found in various plants including Angelica sinensis and Ligusticum chuanxiong. It is widely used in traditional Chinese medicine and has been approved by the State Drugs Administration of China for the treatment of cardiovascular and cerebrovascular diseases. Its pharmacological actions include antithrombotic effects, inhibition of platelet aggregation, antioxidant activity, apoptosis inhibition, and cardioprotection. Mechanistically, it acts as a free radical scavenger (antioxidant), inhibits oxidative stress pathways (including increasing superoxide dismutase activity and nitric oxide levels), suppresses connective tissue growth factor expression in myocardium, and may modulate endothelial function via NO/ERK1/2 signaling pathways. Sodium ferulate has also been studied for potential neuroprotective effects[1][5][6][8][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium ferulate.